ARK Therapeutics Share Discussion Threads

[curlly] 19/3/2013 10:06

Thanks duncan

[duncandisorderly] 19/3/2013 09:56

Look at post 2897.Shell companies have a value as the cost of setting up a new on AIM or any other market can be extreme.Together with the 1 million cash and the 1 million owed to the plc. IMO,

[curlly] 19/3/2013 09:52

Investec Wealth & Investment Limited up there holding to 6.6%
Cant get my head around why people are buying?
Maybe just me

[joeblogg2] 19/3/2013 08:38

duncan. still here unfortunately :(( Just hope something turns up otherwise stand to lose at least £15k> Really amazed how they have squandered so much cash when they were supposed to manage this considering cerepro mess!!

[duncandisorderly] 19/3/2013 08:34

Joe are you still in here or have you bailed.

[cascudi] 18/3/2013 14:45

from today news

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit
---------------------------- --------------- --------------------- ---------------
Purchase 1,425,000 0.91
-------------------------------------------- --------------------- ---------------

[mypension] 18/3/2013 11:04

Thanks Duncan

[duncandisorderly] 18/3/2013 11:01

my pension,I presume with the million pound cash they will have after costs and the just under a million owed to them plus the huge tax write-offs they make the perfect shell company.
If you put these together we should easily be up above the 1p-1.5p mark so time will tell I suppose.
I think it's a waiting game now to see who sticks their head above the parapet and shows an interest in the form of a possible reverse takeover.
I did o.k out of the last one so hopefully history will repeat itself.

[mypension] 18/3/2013 08:43

Can anyone explain why people are still buying. If I knew why I might buy more to average down.

[mypension] 18/3/2013 08:20

News flow about what? The company is sold. What have we got left?

[duncandisorderly] 15/3/2013 22:17

We didn't even get to vote on it.What the hell's the deal there???

[duncandisorderly] 15/3/2013 22:10

They sold the company for peanuts and have no doubt been given a nice back hander.
Corupt,useless,bas*ards.They all need fuc*ing shooting

[crackdown2020] 15/3/2013 18:34

8.3 mil buys at premium price

[mypension] 15/3/2013 15:57

Could it be that some people haven't seen the RNS?

[joeblogg2] 15/3/2013 15:44

No idea myp. Duncan, I hope Phillips and harwood do something here as they are down a bit??

[mypension] 15/3/2013 15:22

Can anyone explain why people are still buying? 100,000 and 500,000 type buys?
Genuine question - I can't understand it.

[joeblogg2] 15/3/2013 14:56

tomb. the woundcare although expected is not guaranteed and there are expenses of 300k for a year until they give back the cash. So hopefully before then some other decent biotech can utilise all the tax losses with the reverse takeover and listing??

[tomboyb] 15/3/2013 14:50

This was @ 3p+ a few weeks back - now @ 0.4p -

As a consequence of the Disposal, Ark Plc will have a net cash balance of approximately £1 million following settlement of all currently outstanding liabilities. Ark Plc is expecting the Woundcare business to continue to perform, so as to trigger the payment obligation of up to £0.926 million (in deferred consideration) as a result of the disposal of the Woundcare business in 2010.

Effectively around £1.9mill possible?

[mypension] 15/3/2013 14:45

I must be a bit thick or I am missing something. Here is my post from yesterday - how can things be so dire when the results seem so good. Surely some bank must have seen the progress.

Just wondering - this is from the RNS on 21 Jan
"The Company has seven active clients, and a number of further contracts in late stage negotiations as well as a growing order book based on a significant number of further client discussions. Unaudited revenue for 2012 was up 300% to c£1.8 million compared to 2011."

and in November last year
"We are pleased to report real progress in the delivery of our vision to become a leading contract development and manufacturing partner for viral drug development. ,,,,As we reported in our interim results, the Company had cash and cash equivalents of £4.9m at 30 June 2012. ...Dr David Venables, CEO of Ark, commented:

"I am deeply encouraged by the progress we have made since the Company transitioned to a services orientated revenue-generating business earlier this year and would like to thank management, staff and shareholders for their continued support of our new business model."

So why are the directors worried - why are they - it seems - trying to sell off the company?

Revenue up 300% cash in June of $4.9 million.???

[duncandisorderly] 15/3/2013 14:43

They have sold everyone down the river and are laughing at shareholders.Total scum!

[joeblogg2] 15/3/2013 14:19

Those directors have completely mismanaged this. I am shocked at the costs and no doubt they got handsomely paid!!